Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss

Genes Chromosomes and Cancer

Volumn 37, Issue 3, 2003, Pages 225-236

  Simpson, D J ^a   Bicknell, E J ^a   Buch, H N ^a   Cutty, S J ^a   Clayton, R N ^a   Farrell, W E ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ARTICLE; CANCER INVASION; CANDIDATE GENE; CARCINOGENESIS; CHROMATIN STRUCTURE; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CHROMOSOME ARM; GENE; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENE LOSS; GENE SILENCING; GROWTH HORMONE SECRETING ADENOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOMA; ALLELES; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; COHORT STUDIES; GENE DELETION; GENOME, HUMAN; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM INVASIVENESS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037870415     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10216     Document Type: Article

References (33)

1. Alexander JM. 2001. Tumor suppressor loss in pituitary tumors. Brain Pathol 11:342-355.
2. Asa S, Ezzat S. 1998. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798-827.
3. Barret MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ. 1996. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12:1873-1878.
4. Bares AS, Farrell WE, Bicknell EJ, Talbot AJ, Broome JC, Perrett CW, Thakker RV, Clayton RN. 1997. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82:818-824.
5. Boggild MD, Jenkinson S, Pistorello M, Boscaro M Scanarini M, Mcternan P, Perrett CW, Thakker RV, Clayton RN. 1994. Molecular generic studies of sporadic pituitary tumours. J Clin Endocrinol Metab 78:387-392.
6. Chung TKH, Cheung TH, Lo WK, Yu MY, Hampton GM, Wong HKT, Wong YF. 2000. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Cancer Lett 154:189-194.
7. Coombes MM, Mao L Steck KD, Luna MA, El-Naggar AK. 1998. Genotypic analysis of flow-sorted and microdissected head and neck squamous lesions by whole genome amplification. Diagn Mol Pathol 7:197-201.
8. Daniely M, Aviram A, Adams EF, Buchfelder M, Barkkai G, Fahlbusch R, Goldman B, Friedman E. 1998. Comparative genomic hybridisation analysis of nonfunctioning pituitary tumors. J Clin Endocrinol Metab 83:1801-1805.
9. Dietmaier W, Hartmann A, Wallinger S, Heinmoller E, Kerner T, Endl E, Jauch K-W, Hofstadter F, Ruschoff J. 1999. Multiple mutation analysis in single tumour cells with improved whole genome amplification. Am J Pathol 154:83-94.
10. Farrell WE, Clayton RN. 2000. Molecular pathogenesis of pituitary rumors. Front Neuroendocrinol 21:174-198.
11. Farrell WE, Simpson DJ, Bicknell EJ, Talbot AJ, Bares AS, Clayton RN. 1997. Chromosome 9p deletions in invasive and non-invasive non-functional pituitary adenomas; the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Res 57:2703-2709.
12. Fearon ER, Vogelstein BA. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
13. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. 2000. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60:4894-4906.
14. Harada K, Nishizaki T, Ozaki S, Kubota H, Harada K, Okamura T, Ito H, Sasaki K. 1999. Cytogenetic alterations in pituitary adenomas detected by comparative genomic hybridization. Cancer Genet Cytogenet 112:38-41.
15. Hardy J. 1979. Transphenoidal microsurgical treatment of pituitary tumours. In: Linfoot J, editor. Recent advances in the diagnosis and treatment of pituitary tumours. New York: Raven Press. p 375-388.
16. Hui ABY, Pang JCS, Ko C-W, Ng H-K. 1999. Detection of chromosomal imbalances in growth hormone-secreting pituitary tumors by comparative genomic hybridisation. Hum Pathol 30:1019-1023.
17. Kristjansson K, Chong SS, Van den Veyver IB, Subramanian S, Snabes MC, Hughes MR. 1994. Preimplantation single cell analyses of dystophin gene deletions using whole genome amplification. Nat Genet 6:19-23.
18. Pei L, Melmed S, Scheithauer B, Kovaks K, Benedict WF, Prager D. 1995. Frequent loss of heterozygosity at the retinoblastoma susceptibility (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55:1613-1616.
19. Pernicone PJ, Scheithauer B, Sebo TJ, Kovacs K, Horvath E, Young WF Jr, Lloyd RV, Davis DH, Guthrie BL, Schoene WC. 1997. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79:804-812.
20. Prezant TP, Levine J, Melmed S. 1998. Molecular characterisation of the MEN1 tumour suppressor gene in sporadic pituitary tumours. J Clin Endocrinol Metab 83:1388-1391.
21. Rickert CH, Scheithauer BW, Paulus W. 2001. Chromosomal aberrations in pituitary carcinoma metastases. Acta Neuropathol 102:117-120.
22. Simoneau M, Aboulkassim TO, Larue H, Rousseau F, Fradet Y. 1999. Four tumour suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31. Oncogene 18:157-163.
23. Simpson DJ, Bicknell EJ, McNicol AM, Clayton RN, Farrell WE. 1999a. Hypermethylation of the p16/CDKN2a/MTS1 gene and loss of protein expression is associated with non-functional pituitary adenomas but not somatotrophinomas. Genes Chromosomes Cancer 24:328-336.
24. Simpson DJ, Magnay J, Bicknell EJ, Barkan AL, McNicol AM, Clayton RN, Farrell WE. 1999b. Chromosome 13q deletion mapping in pituitary tumours: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas. Cancer Res 59:1562-1566.
25. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE. 2000. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res 60:1211-1216.
26. Sun F, Arnheim N, Waterman MS. 1995. Whole genome amplification of single cells: mathematical analysis of PEP and tagged PCR. Nucleic Acids Res 11:3034-3040.
27. Thakker RV. 1996. Role of chromosome 11 in hereditary and sporadic pituitary tumourigenesis. Front Horm Res 20:179-193.
28. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN. 1993. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91:2815-2821.
29. Tong Y-KC, Zheng PP, Pang JC-S, Poon W-S, Chang AR, Ng H-K. 2001. Identification of novel regions of allelic loss in ependymomas by high resolution allelotyping with 384 microsatellite markers. J Neurosurg 95:9-14.
30. Trautmann K, Thakker RV, Ellison DW, Ibrahim A, Lees PD, Harding B, Fischer C, Popp S, Bartmram CR, Jauch A. 2001. Chromosomal aberrations in sporadic pituitary tumors. Int J Cancer 91:809-814.
31. Vogelstein B, Fearon E, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R. 1989. Allelotype of colorectal carcinomas. Science 244:207-211.
32. Yu R, Melmed S. 2001. Oncogene activation in pituitary tumors. Brain Pathol 11:328-341.
33. Zhuang Z, Ezzat S, Vortmeyer AO, Weil R, Oldfield EH, Park WS, Pack S, Huang S, Agarwal SK, Guru SC, Manickam P, Debelenko LV, Kester MB, Olufemi SE, Heppner C, Crabtree JS, Burns AL, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Emmert-Buck MR, Liotta LA, Asa SL, Lubensky IA. 1997. Mutation of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57:5446-5451.